Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Samsung Biologics is a globally recognized Contract Development and Manufacturing Organization (CDMO) offering end-to-end services for the biopharmaceutical industry. From cell line development and process development to cGMP drug substance and drug product manufacturing, Samsung Biologics partners with pharmaceutical companies worldwide to bring innovative therapies to patients. They are known for their large-scale manufacturing capacity, operational excellence, and commitment to quality and speed.
The headquarters serves as the central command for corporate management, research and development, process development, and houses some of the world's largest biomanufacturing plants (Bio Plants I, II, III, IV, and V under construction).
Home to the 'Bio Campus,' featuring multiple large-scale cGMP manufacturing plants with a current operational capacity exceeding 604,000 liters, making it one of the largest biomanufacturing sites globally. Advanced automation, sustainable design, and continuous expansion are key features.
A dynamic culture focused on speed, quality, innovation, and client collaboration. There's a strong emphasis on continuous improvement, operational excellence, and adherence to stringent global regulatory standards, fostering employee development in a high-tech, fast-paced environment.
The Songdo headquarters is pivotal to Samsung Biologics' global strategy, serving as its primary production and innovation center. Its massive scale and advanced technological capabilities position it as a critical player in the global biopharmaceutical supply chain.
Samsung Biologics supports a global client base from its main hub in South Korea and through regional offices in the United States. The company provides end-to-end CDMO services, including cell line development, process development, clinical and commercial scale cGMP manufacturing of drug substance and drug product, and aseptic fill/finish services to pharmaceutical and biotechnology companies across North America, Europe, Asia, and other international markets. Their robust global supply chain ensures the reliable delivery of biopharmaceuticals worldwide.
300, Songdo bio-daero, Yeonsu-gu
Incheon
Incheon
South Korea
Address: 101 Main Street, Suite 1650, Cambridge, MA 02142, USA
To strengthen presence and support clients in the strategically important US East Coast biotechnology ecosystem, fostering collaborations and ensuring seamless project management.
Address: 201 Gateway Blvd, Suite D, South San Francisco, CA 94080, USA
To expand outreach and provide localized support to clients in the dynamic West Coast biopharma market, enhancing project communication and partnership development for development and manufacturing services.
Address: 85 Challenger Road, Ridgefield Park, NJ 07660, USA
To enhance service offerings and accessibility for US clients, particularly for contract development (CDO) services, by establishing a local R&D presence and bolstering client support functions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Samsung Biologics' leadership includes:
Samsung Biologics has been backed by several prominent investors over the years, including:
Samsung Biologics' core executive leadership has demonstrated stability over the past 12 months, a period marked by continued growth and operational expansion. While internal promotions and strategic team enhancements are ongoing to support its global ambitions, no major C-suite or publicly announced top-tier executive hires from external sources or prominent departures have been noted in the publicly available records for Samsung Biologics directly during this specific timeframe (approx. June 2023 - June 2024). This indicates a steady leadership team guiding the company's strategic initiatives.
Discover the tools Samsung Biologics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Samsung Biologics, like many large corporations, likely utilizes standardized email formats for professional communication. While the exact primary format isn't publicly disclosed, common corporate patterns (often firstname.lastname or initiallastname) are typically employed. The domain used is @samsungbiologics.com.
[first].[last]@samsungbiologics.com or [f][last]@samsungbiologics.com
Format
jane.doe@samsungbiologics.com
Example
85%
Success rate
Korea Biomedical Review • May 28, 2024
Samsung Biologics has secured a $242 million contract to manufacture an antibody-drug conjugate (ADC) for a European pharmaceutical company. This deal highlights Samsung Biologics' expansion into the ADC market and its growing global partnerships....more
Samsung Biologics Press Release • April 24, 2024
Samsung Biologics announced robust financial results for Q1 2024, with consolidated revenues of KRW 946.9 billion and an operating profit of KRW 232.3 billion. The growth was driven by the stable operation of Plant 4 and a strong backlog of orders, showcasing sustained business momentum....more
Samsung Biologics Press Release • February 19, 2024
Samsung Biologics announced plans to open a new Contract Development Organization (CDO) R&D center in New Jersey, USA. This expansion aims to enhance its service offerings and provide localized R&D capabilities for its U.S. clients, further solidifying its position in the key American biopharma market....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Samsung Biologics, are just a search away.